• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康黑人男性中较低的前列腺健康指数、[-2]前列腺特异性抗原/游离前列腺特异性抗原比值以及睾酮/雌二醇比值:初步结果及对前列腺癌临床管理的潜在影响

Lower PHI, [-2]proPSA/fPSA and testosterone/estradiol ratios in healthy black men: preliminary results and potential implications in prostate cancer clinical management.

作者信息

Ferro Matteo, De Cobelli Ottavio, Crocetto Felice, Carbone Gianluigi, Mirto Benito F, Fiorenza Mariano, Falcone Alfonso, La Civita Evelina, Fallara Giuseppe, Musi Gennaro, Rocco Bernardo, Fiori Cristian, Porpiglia Francesco, Terracciano Daniela

机构信息

Division of Urology, European Institute of Oncology (IEO) IRCCS, Milan, Italy.

Department of Neurosciences, Sciences of Reproduction and Odontostomatology, University of Naples Federico II, Naples, Italy.

出版信息

Minerva Urol Nephrol. 2025 Feb;77(1):52-56. doi: 10.23736/S2724-6051.24.05667-2. Epub 2024 Aug 2.

DOI:10.23736/S2724-6051.24.05667-2
PMID:39093222
Abstract

BACKGROUND

Black men residing in Western countries are more likely to develop prostate cancer (PCa), have higher mortality and are younger than the general population at initial diagnosis. In addition to genetic and environmental factors, the reasons for these racial disparities can also be attributed to social determinants of health such as low health literacy of this population and poor awareness of health services. Little is known about laboratory tests for PCa in black men.

METHODS

In this preliminary study. we investigated whether ethnicity affect PSA molecular forms, PHI, estradiol and testosterone levels in healthy men.

RESULTS

We found that healthy black men had lower PHI, [-2]proPSA/fPSA and testosterone/estradiol ratios.

CONCLUSIONS

Our findings even if on a small study population could have a relevant clinical impact. since PCa screening is particularly relevant in black men who are at high risk of clinically significant PCa. PSA-based screening is needed and overdiagnosis must be avoided. Our findings could be particularly impactful. Future research on larger population needs to consider whether ethnicity specific laboratory tests thresholds could help to reduce the ethnic inequalities in prostate cancer diagnosis.

摘要

背景

居住在西方国家的黑人男性患前列腺癌(PCa)的可能性更高,死亡率更高,且初次诊断时比普通人群更年轻。除了遗传和环境因素外,这些种族差异的原因还可归因于健康的社会决定因素,如该人群的健康素养低和对医疗服务的认知不足。关于黑人男性前列腺癌的实验室检测知之甚少。

方法

在这项初步研究中,我们调查了种族是否会影响健康男性的前列腺特异性抗原(PSA)分子形式、前列腺健康指数(PHI)、雌二醇和睾酮水平。

结果

我们发现健康的黑人男性的PHI、[-2]前体PSA/游离PSA和睾酮/雌二醇比值较低。

结论

我们的研究结果即使是基于小样本研究人群,也可能产生相关的临床影响。因为前列腺癌筛查对临床上有显著前列腺癌高风险的黑人男性尤为重要。需要进行基于PSA的筛查,且必须避免过度诊断。我们的研究结果可能具有特别的影响力。未来对更大人群的研究需要考虑种族特异性实验室检测阈值是否有助于减少前列腺癌诊断中的种族不平等。

相似文献

1
Lower PHI, [-2]proPSA/fPSA and testosterone/estradiol ratios in healthy black men: preliminary results and potential implications in prostate cancer clinical management.健康黑人男性中较低的前列腺健康指数、[-2]前列腺特异性抗原/游离前列腺特异性抗原比值以及睾酮/雌二醇比值:初步结果及对前列腺癌临床管理的潜在影响
Minerva Urol Nephrol. 2025 Feb;77(1):52-56. doi: 10.23736/S2724-6051.24.05667-2. Epub 2024 Aug 2.
2
Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS project.家族性前列腺癌病史男性患者中血清前列腺特异性抗原同工型 [-2]proPSA(p2PSA)及其衍生物%p2PSA 和前列腺健康指数(PHI)的临床性能:来自多国欧洲研究——PROMEtheuS 项目的结果。
BJU Int. 2013 Aug;112(3):313-21. doi: 10.1111/bju.12217.
3
Diagnostic accuracy of prostate health index to identify aggressive prostate cancer. An Institutional validation study.前列腺健康指数用于识别侵袭性前列腺癌的诊断准确性:一项机构验证研究
Actas Urol Esp. 2016 Jul-Aug;40(6):378-85. doi: 10.1016/j.acuro.2016.01.004. Epub 2016 Feb 26.
4
Serum isoform [-2]proPSA derivatives significantly improve prediction of prostate cancer at initial biopsy in a total PSA range of 2-10 ng/ml: a multicentric European study.血清同工型 [-2]前列腺特异性抗原衍生物在总 PSA 范围为 2-10ng/ml 时显著改善了初始活检前列腺癌的预测:一项多中心欧洲研究。
Eur Urol. 2013 Jun;63(6):986-94. doi: 10.1016/j.eururo.2013.01.011. Epub 2013 Jan 24.
5
Serum (-2)proPSA/freePSAratio, (-2)proPSA/freePSA density, prostate health index, and prostate health index density as clues to reveal postoperative clinically significant prostate cancer in men with prostate-specific antigen 2-10 ng/mL.血清(-2)前列腺特异性抗原/游离前列腺特异性抗原比值、(-2)前列腺特异性抗原/游离前列腺特异性抗原密度、前列腺健康指数和前列腺健康指数密度作为线索,以揭示前列腺特异性抗原 2-10ng/ml 男性术后临床显著前列腺癌。
Prostate. 2024 Sep;84(12):1157-1164. doi: 10.1002/pros.24752. Epub 2024 May 26.
6
From prostate-specific antigen (PSA) to precursor PSA (proPSA) isoforms: a review of the emerging role of proPSAs in the detection and management of early prostate cancer.从前列腺特异性抗原(PSA)到前体 PSA(proPSA)同工型:对 proPSA 在早期前列腺癌检测和管理中新兴作用的综述。
BJU Int. 2013 Oct;112(6):717-28. doi: 10.1111/j.1464-410X.2012.11329.x. Epub 2012 Jul 3.
7
Usefulness of the prostate health index in predicting the presence and aggressiveness of prostate cancer among Korean men: a prospective observational study.前列腺健康指数在预测韩国男性前列腺癌的存在和侵袭性方面的作用:一项前瞻性观察研究。
BMC Urol. 2021 Sep 16;21(1):131. doi: 10.1186/s12894-021-00897-2.
8
Clinical performance of serum isoform [-2]proPSA (p2PSA), and its derivatives %p2PSA and the Prostate Health Index, in men aged <60 years: results from a multicentric European study.血清同工型[-2]前列腺特异性抗原(p2PSA)及其衍生物%p2PSA和前列腺健康指数在60岁以下男性中的临床性能:一项欧洲多中心研究的结果
BJU Int. 2015 Jun;115(6):913-20. doi: 10.1111/bju.12718. Epub 2015 Mar 26.
9
PSA Isoforms' Velocities for Early Diagnosis of Prostate Cancer.前列腺癌早期诊断中前列腺特异性抗原(PSA)异构体的速度
Anticancer Res. 2015 Jun;35(6):3567-70.
10
ProPSA and the Prostate Health Index as predictive markers for aggressiveness in low-risk prostate cancer-results from an international multicenter study.ProPSA 和前列腺健康指数作为低危前列腺癌侵袭性的预测标志物——一项国际多中心研究的结果。
Prostate Cancer Prostatic Dis. 2017 Sep;20(3):271-275. doi: 10.1038/pcan.2017.3. Epub 2017 Mar 21.

引用本文的文献

1
Blood and urine-based biomarkers in prostate cancer: Current advances, clinical applications, and future directions.前列腺癌中基于血液和尿液的生物标志物:当前进展、临床应用及未来方向
J Liq Biopsy. 2025 Jun 16;9:100305. doi: 10.1016/j.jlb.2025.100305. eCollection 2025 Sep.
2
Integrative analysis of blood biomarkers and clinical variables improves early detection of aggressive prostate cancer.血液生物标志物与临床变量的综合分析可改善侵袭性前列腺癌的早期检测。
Sci Rep. 2025 Apr 23;15(1):14071. doi: 10.1038/s41598-025-98980-3.